Bajaj Healthcare Limited schedules board meeting for May 08, 2026 to approve audited financial results for Q4 and FY ending March 31, 2026.
Board will consider recommending final dividend for FY 2025-26, subject to shareholder approval at upcoming AGM.
Trading window closure for insiders remains in effect from April 01, 2026 until 48 hours after results declaration.